+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "BMS 986231"

Heart Failure - Pipeline Insight, 2024 - Product Thumbnail Image

Heart Failure - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 300 Pages
  • Global
From
From
BMS-986231 - Product Thumbnail Image

BMS-986231

  • Report
  • February 2018
  • 11 Pages
  • Global
From
Drug Analysis: BMS-986231 - Product Thumbnail Image

Drug Analysis: BMS-986231

  • Drug Pipelines
  • February 2018
  • 11 Pages
  • Global
From
  • 4 Results (Page 1 of 1)
Loading Indicator

The BMS 986231 market is a segment of the cardiovascular drugs industry. It is composed of pharmaceuticals and biologics used to treat a variety of cardiovascular conditions, such as hypertension, coronary artery disease, and congestive heart failure. These drugs are used to reduce the risk of stroke, heart attack, and other cardiovascular events. They can also be used to improve the quality of life for those with existing cardiovascular conditions. The BMS 986231 market is highly competitive, with many large pharmaceutical companies vying for market share. Companies in the market include Pfizer, Merck, Novartis, Sanofi, and Bristol-Myers Squibb. These companies are engaged in research and development of new drugs, as well as marketing and distribution of existing products. Additionally, many smaller companies are involved in the production and sale of generic versions of these drugs. Show Less Read more